Showing results (171-180 of 288) with videos related to
Sort By:
Pageof 29
Gynecologic Oncology|March 30, 2020
Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical careLuke McLean, James R Whittle, Jonathan Graham, et al.Head & Neck|October 14, 2015
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinomaDamien Urban, June Corry, Ben Solomon, et al.International Journal of Radiation Oncology, Biology, Physics|November 10, 2020
Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional StudyGeorgina Casswell, Karla Gough, Allison Drosdowsky, et al.Oral Oncology|October 24, 2022
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selectionMario Tapia, Jamil Manji, Kaman Dhillon, et al.Oral Oncology|October 15, 2021
Symptom burden, quality of life, functioning and emotional distress in survivors of human papillomavirus associated oropharyngeal cancer: An Australian cohortLachlan McDowell, Georgina Casswell, Mathias Bressel, et al.Cancer|November 30, 2006
How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET/CT?Guohui Wang, Eddie W F Lau, Ramdave Shakher, et al.Oral Oncology|March 11, 2015
Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiationKetan Shah, Luc Te Marvelde, Marnie Collins, et al.Cancers|April 27, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint InhibitorsLuke S McLean, Annette M Lim, Christopher Angel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology GroupDanny Rischin, Lester J Peters, Brian O'Sullivan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibitionJoan Albanell, Federico Rojo, Steve Averbuch, et al.Pageof 29